PMID: 8596268Feb 24, 1996Paper

Haloperidol antagonism of cue-elicited cocaine craving

Lancet
S P BergerS Hall

Abstract

Studies of cocaine-dependent subjects have shown that re-exposure to environmental cues previously associated with cocaine use produces a strong conditioned response characterised by autonomic hyperarousal and increases in subjective measures of cocaine craving. To evaluate the role of dopamine release by such cues, 20 cocaine-dependent inpatients were randomised in a single-dose, crossover, placebo-controlled design, to haloperidol (4 mg by mouth) and placebo. Plasma homovanillic acid (HVA, a dopamine metabolite), adrenocorticotropic hormone (ACTH), and cortisol were assayed before and after cue exposure. Craving and anxiety were measured before and after cues with visual analogue scales for desire to use cocaine now and for mood changes. Cocaine cues significantly increased anxiety, ACTH, cortisol, and HVA. Increases in anxiety and craving resulting from cue exposure were significantly antagonised by pretreatment with haloperidol. It has long been hypothesised that increases in extracellular concentrations of dopamine mediate the acute reinforcing effects of cocaine. Our data suggest that dopamine release may also mediate some of the conditioned responses to cocaine cues.

References

Jul 1, 1992·Biological Psychiatry·G KnoblichR King
Nov 1, 1992·British Journal of Addiction·H R Kranzler, L O Bauer
Jan 1, 1992·Schizophrenia Bulletin·F AminK L Davis
Jul 1, 1991·Trends in Neurosciences·M J KuharJ W Boja
Jan 1, 1991·Archives of General Psychiatry·A MargolinT Kosten
Aug 1, 1989·Biological Psychiatry·S D MartinM P Galloway
Apr 1, 1987·Psychiatry Research·C A DackisR Climko
Feb 1, 1986·Archives of General Psychiatry·F H Gawin, H D Kleber
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Jul 1, 1994·Trends in Pharmacological Sciences·P Seeman, H H Van Tol
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge

❮ Previous
Next ❯

Citations

Sep 2, 1998·Synapse·S L DeweyJ D Brodie
May 13, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Natasa MilivojevicMarko Zivin
Mar 15, 2011·Psychopharmacology·Michelle L JobesKenzie L Preston
Aug 22, 2007·Cellular and Molecular Neurobiology·Hongyuan ChuXuechu Zhen
May 26, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Debra S HarrisReese T Jones
Jul 26, 2002·Brain Research·Andrew B NormanVladimir L Tsibulsky
Nov 5, 1997·Pharmacology, Biochemistry, and Behavior·S PeciñaL A Parker
Aug 26, 1999·Pharmacology, Biochemistry, and Behavior·B Partridge, S Schenk
Jul 15, 1998·Neuroscience and Biobehavioral Reviews·J L HaraczG V Rebec
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Jan 19, 2000·Trends in Pharmacological Sciences·A R Childress, C P O'Brien
Jun 6, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ingmar H A Franken
Oct 2, 1998·Neuroscience Letters·A N ToppleI S McGregor
May 22, 2003·Drug and Alcohol Dependence·Kyle M KampmanCharles P O'Brien
Nov 1, 1996·Drug and Alcohol Dependence·R N EhrmanC P O'Brien
Aug 25, 1997·Drug and Alcohol Dependence·R W Foltin, M W Fischman
Apr 17, 1998·Drug and Alcohol Dependence·M S ReidS P Berger
Mar 18, 1999·Drug and Alcohol Dependence·S J RobbinsC P O'Brien
Mar 9, 2000·Drug and Alcohol Dependence·S J RobbinsC P O'Brien
Aug 15, 2000·Drug and Alcohol Dependence·L A SellR J Dolan
Sep 22, 2005·Experimental and Clinical Psychopharmacology·Karen M AlseneHarriet de Wit
Mar 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Evan N GrafJohn R Mantsch
Apr 3, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Aryandokht FotrosMarco Leyton
Sep 5, 2002·Nature Reviews. Drug Discovery·Philippe Pouletty
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Malcolm S ReidLeslie S Prichep
Sep 15, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dean F WongEdythe D London
Jan 4, 2003·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Gopakumar P. Panikkar
Mar 16, 2005·Behavioural Pharmacology·S V Mahler, H de Wit
Jul 11, 2013·Behavioural Pharmacology·Jermaine D Jones, Sandra D Comer
Oct 30, 2001·Journal of Addictive Diseases·J P MezinskisE Somoza
Oct 30, 2001·Journal of Addictive Diseases·T Winhusen, E Somoza
Jul 17, 2004·Journal of Addictive Diseases·Gene-Jack WangJoanna S Fowler
Jul 19, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evan N GrafPaul J Gasser
Jan 16, 2016·Addiction Biology·Elizabeth B de Sousa Fernandes PernaJohannes G Ramaekers
Jul 26, 2011·Biological Psychiatry·Rachel J Smith, Gary Aston-Jones
Dec 29, 2009·Behavioural Brain Research·Patrick Anselme
Jun 2, 2009·Behavioural Brain Research·Rick E BernardiS Paul Berger
Apr 21, 2009·Drug and Alcohol Dependence·Malcolm S Reid, Vatsal Thakkar
Sep 24, 2008·Pharmacology, Biochemistry, and Behavior·Zhen-Yu RenLin Lu
Jul 29, 2008·Neuropharmacology·Paul Vezina, Marco Leyton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here